- Trials with a EudraCT protocol (39)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
39 result(s) found for: Crown.
Displaying page 1 of 2.
| EudraCT Number: 2021-001885-40 | Sponsor Protocol Number: Syst-AB+Sinus | Start Date*: 2022-02-24 |
| Sponsor Name:Universidad Complutense de Madrid | ||
| Full Title: The effect of systemic antibiotics on post-surgical complications and paitent-centered outomes in patients undergoing implant surgery with the guided bone regeneration and simultaneous sinus floor ... | ||
| Medical condition: The medical condition that the patients have in this trial is edentulism in a posterior maxillary quadrant of the mouth with a sinus pneumatisation/ decreased crestal bone heigh defect requiring a... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-002694-19 | Sponsor Protocol Number: 62449 | Start Date*: 2018-02-22 |
| Sponsor Name:Radboud University Medical Centre | ||
| Full Title: Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: a randomized double blind placebo-controlled comparison (M&M trial). | ||
| Medical condition: Early pregnancy failure | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-019955-23 | Sponsor Protocol Number: LWH 0852 | Start Date*: 2010-12-29 |
| Sponsor Name:Liverpool Women's NHS Foundation Trust [...] | ||
| Full Title: To evaluate the pharmakcokinetics, tolerability and short term safety of ciprofloxacin in neonates and infants with suspected (or proven) Gram Negative Infection Open Label pilot PK study - TINN T... | ||
| Medical condition: Pharmacokinetics of ciprofloxacin used for suspected or proven gram negative sepsis. | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-003307-36 | Sponsor Protocol Number: LWH0606 | Start Date*: 2005-12-08 |
| Sponsor Name:University of Liverpool/Liverpool Women's Hospital | ||
| Full Title: A randomised controlled trial of prednisolone for women with recurrent miscarriage and high levels of uNK cells in the endometrium | ||
| Medical condition: Idopathic recurrent miscarriage | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-000599-33 | Sponsor Protocol Number: LWH0646 | Start Date*: 2006-08-21 |
| Sponsor Name:Liverpool Women's NHS Foundation Trust | ||
| Full Title: Duration of luteal phase support with progesterone pessaries to improve the success rate in assisted reproduction cycles. A prospective randomised control trial. | ||
| Medical condition: Women undergoing assisted conception | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-005738-12 | Sponsor Protocol Number: LIPSTIC.V.01 | Start Date*: 2013-03-27 |
| Sponsor Name:Alder Hey Children's NHS Foundation Trust | ||
| Full Title: Liverpool Pharmacokinetic/pharmacodynamics study of teicoplanin in children (LIPSTIC). | ||
| Medical condition: Gram-positive bacterial infection: late-onset neonatal sepsis, central line-associated blood stream infection, ventilator-associated pneumonia. | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-006617-32 | Sponsor Protocol Number: 06/Q0605/1 | Start Date*: 2007-05-02 |
| Sponsor Name:Kings College Hospital Trust R&D | ||
| Full Title: A prospective randomised double blind parallel trial comparing Articaine versus Lignocaine for mandibular dentistry | ||
| Medical condition: necessary dental surgery | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-002952-34 | Sponsor Protocol Number: ACH-UCP-301 | Start Date*: 2015-12-07 | |||||||||||
| Sponsor Name:Atlantic Pharmaceuticals Limited | |||||||||||||
| Full Title: A Randomised, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects with Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis | |||||||||||||
| Medical condition: Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) NL (Completed) IE (Completed) BE (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-008899-14 | Sponsor Protocol Number: LWH0776 | Start Date*: 2009-06-25 |
| Sponsor Name:Liverpool Women's NHS Foundation Trust | ||
| Full Title: Standardised, Concentrated, Additional Macronutrients, Parenteral (SCAMP) nutrition in very preterm infants: a phase IV randomised controlled study of macronutrient intake, growth and implications ... | ||
| Medical condition: Prematurity | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-000832-28 | Sponsor Protocol Number: LWH0642 | Start Date*: 2006-07-04 |
| Sponsor Name:Liverpool Women's NHS Foundation Trust | ||
| Full Title: Dopamine pharmacokinetics in extremely premature infants: a pilot study | ||
| Medical condition: Neonatal hypotension | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-000585-38 | Sponsor Protocol Number: SQ411218 | Start Date*: 2019-08-20 |
| Sponsor Name:University Hospitals Coventry and Warwickshire NHS Trust | ||
| Full Title: Chronic Endometritis and Recurrent Miscarriage - The CERM trial | ||
| Medical condition: Chronic Endometritis and Recurrent Miscarriage | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001402-38 | Sponsor Protocol Number: CTU/2020/352 | Start Date*: 2020-10-20 | |||||||||||
| Sponsor Name:University College London | |||||||||||||
| Full Title: An international, Bayesian platform adaptive, randomized, placebo-controlled trial assessing the effectiveness of candidate interventions in preventing COVID-19 disease in healthcare workers. | |||||||||||||
| Medical condition: Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-001554-10 | Sponsor Protocol Number: NL57892 | Start Date*: 2016-06-21 | ||||||||||||||||
| Sponsor Name:Radboudumc | ||||||||||||||||||
| Full Title: Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: a pilot study | ||||||||||||||||||
| Medical condition: Women aged above 18 years with early pregnancy failure, 6-14 weeks postmenstrual. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Female | |||||||||||||||||
| Trial protocol: NL (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2017-001007-72 | Sponsor Protocol Number: 80-84800-98-41027 | Start Date*: 2017-07-06 |
| Sponsor Name:Amsterdam UMC location AMC | ||
| Full Title: Atosiban versus placebo in the treatment of late threatened preterm birth (APOSTEL VIII). | ||
| Medical condition: Neonatal outcome in threatened preterm birth between 30 and 34 weeks of gestation. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: NL (Completed) GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-002982-20 | Sponsor Protocol Number: 5155 | Start Date*: 2020-01-29 | ||||||||||||||||
| Sponsor Name:Royal Liverpool University Hospital | ||||||||||||||||||
| Full Title: A Pilot Study to assess the efficacy and safety of reduced dose oral iron in the treatment of iron deficiency anaemia in inflammatory bowel disease patients | ||||||||||||||||||
| Medical condition: Iron deficiency anaemia in inflammatory bowel disease | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2005-003099-39 | Sponsor Protocol Number: LWH0604 | Start Date*: 2008-08-21 |
| Sponsor Name:Liverpool Women's NHS Foundation Trust Hospital | ||
| Full Title: A Randomised Controlled Trial of Thyroxine in Preterm Infants Under 28 weeks' Gestation. | ||
| Medical condition: Hypothyroidism is a condition where there is a lack of thyroid hormone in the body. Thyroid hormones are important for normal brain development and growth. Children who are born with low thyroid ho... | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-002949-20 | Sponsor Protocol Number: LWH0747 | Start Date*: 2008-04-28 | |||||||||||
| Sponsor Name:Liverpool Women's NHS Foundation Trust | |||||||||||||
| Full Title: Randomised controlled trial comparing the effects of oxytocin 5 units IV bolus vs oxytocin 5 units IV infusion on cardiac output during caesarean section | |||||||||||||
| Medical condition: The drug is given routinely to women during caesarean section to help the womb contract after their baby has been delivered. This helps reduce the risk of bleeding after surgery. For this trial, ... | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-001939-27 | Sponsor Protocol Number: SystABSinus01 | Start Date*: 2021-02-25 |
| Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Zahn-, Mund- und Kieferheilkunde | ||
| Full Title: The effect of systemic antibiotics on post-surgical complications and patient-centered outcomes in patients undergoing implant surgery with guided bone regeneration and simultaneous sinus floor ele... | ||
| Medical condition: patients undergoing oral implant therapy with simultaneous lateral sinus floor elevation and guided bone regeneration (GBR) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-002905-89 | Sponsor Protocol Number: 20186 | Start Date*: 2022-10-19 |
| Sponsor Name:BAYER AG | ||
| Full Title: An 18-month, open-label, single-arm safety extension study of an age-and bodyweight-adjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children and young adults f... | ||
| Medical condition: Treatment of children with chronic kidney disease and proteinuria | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: IT (Trial now transitioned) ES (Trial now transitioned) BE (Trial now transitioned) NL (Trial now transitioned) AT (Trial now transitioned) DK (Trial now transitioned) GR (Trial now transitioned) CZ (Trial now transitioned) SE (Trial now transitioned) PL (Trial now transitioned) LT (Trial now transitioned) FR (Trial now transitioned) PT (Trial now transitioned) DE (Trial now transitioned) FI (Trial now transitioned) HU (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-004478-41 | Sponsor Protocol Number: LCC001 | Start Date*: 2015-03-10 | |||||||||||
| Sponsor Name:King's College London [...] | |||||||||||||
| Full Title: Phase III trial in IntrahepaTic CHolestasis of pregnancy (ICP) to Evaluate urSodeoxycholic acid (UDCA) in improving perinatal outcomes | |||||||||||||
| Medical condition: Intrahepatic Cholestasis of pregnancy | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
